Schema Focused Therapy for Chronic Depression
Schema focused therapy (SFT) is an innovative treatment approach to chronic, lifelong problems that incorporates cognitive, behavioral, experiential and psychodynamic elements and techniques. This study will determine whether SFT is a suitable and effective treatment for chronic depression in terms of acute effects and the prevention of relapse/recurrence. The secondary aim of this study is to identify the underlying mechanisms of change in SFT that lead to recovery from depression and the prevention of future relapse/recurrence.
|Study Design:||Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Schema-Focused Therapy for Chronic Depression: Efficacy and Mechanisms of Change|
- Depressive symptom improvement [ Time Frame: Weekly during baseline and intervention; Monthly during follow-up ] [ Designated as safety issue: No ]
- Depressive relapse/recurrence [ Time Frame: Measured at 12 month follow-up ] [ Designated as safety issue: No ]
|Study Start Date:||January 2011|
|Estimated Study Completion Date:||September 2014|
|Estimated Primary Completion Date:||September 2013 (Final data collection date for primary outcome measure)|
Experimental: Schema Focused Therapy
Participants will receive Schema Focused Therapy
Behavioral: Schema Focused Therapy
SFT is a novel treatment approach to chronic, lifelong problems that incorporates cognitive, behavioral, experiential and psychodynamic elements and techniques. In the present study participants will receive up to 75 individual sessions of SFT depending on the individual progress in therapy.
A single-case series design with multiple randomized baselines across participants will be used in this study. The study will last approximately 36 months and comprises three phases. The first phase is a 6-12 weeks waiting list/baseline phase during which participants will be repeatedly assessed with the main outcome measures and putative mediators. In the second phase participants will receive up to 75 individual sessions of SFT for chronic depression depending on the individual progress in therapy. Upon completion of the intervention phase, participants will have monthly follow-up assessments for the next 12 months.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01153867
|Contact: Fritz Renner, MSc.||+31(0)firstname.lastname@example.org|
|Contact: Marcus Huibers, PhD||+31(0)email@example.com|
|Academic Community Mental Health Center, Riagg||Recruiting|
|Maastricht, Limburg, Netherlands, 6221BD|
|Contact: Marcus Huibers, PhD +31(0)433881228 firstname.lastname@example.org|
|Principal Investigator:||Fritz Renner, MSc.||Department of Clinical Psychological Science, Maastricht University|
|Study Director:||Marcus Huibers, PhD||Department of Clinical Psychological Science, Maastricht University|